Subscribe to RSS
DOI: 10.1055/s-0041-1735201
Three Technologies That Will Guide Revascularization of Chronic Coronary Syndrome Patients into the 21st Century: A Review
Funding Dr. Winkler receives research support from Terarecon, Ziosoft, Algomedica, and Teleflex. Dr. Arora receives research support from Terarecon. Dr. Weintraub is funded by grants from the National Institutes of Health (HL142097, HL134354, R56AG064895, and AR070029).

Abstract
Although medical therapy is the preferred first-line treatment for patients with chronic coronary syndrome (CCS), revascularization remains an important consideration. We present a review that identifies the three diagnostic technologies most important to guiding the decision to revascularize patients with CCS: (1) cardiac computed tomography, (2) intracoronary imaging, and (3) lesion-specific physiological guidance.
Keywords
chronic coronary syndrome - medical therapy - revascularization - intravascular ultrasound - optical coherence tomography - cardiac computed tomography - fractional flow reserve - instantaneous wave-free ratioAuthors' Contributions
MW substantially contributed to the concept and design, drafting of the manuscript, literature review, summary and qualitative synthesis of publications related to noninvasive cardiovascular imaging and intracoronary imaging, and selection and annotation of figures.
RP was involved in literature review, some drafting, qualitative synthesis of publications related to lesion specific physiological guidance, and selection and annotation of figures.
WF was involved in literature review, some drafting, editing, and manuscript preparation.
VA was involved in concept and design, editing, and minor drafting.
NW was involved in concept and design, editing, final draft, integrity of the manuscript.
Publication History
Article published online:
25 August 2021
© 2021. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA